US2011034494A1PendingUtilityA1
Reversible inhibition of sperm receptor synthesis for contraception
Est. expiryAug 4, 2026(~0 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 15/18A61K 31/17A61K 31/505A61P 15/16
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are disclosed for reversibly inhibiting sperm receptor activity in animals. Nicarbazin, its derivatives and modifications which retain pharmacological activity are shown to inhibit activity of zona pellucida proteins and concomitant synthesis and/or assembly of the sperm receptor on the oocyte surface necessary for fertilization. Nicarbazin is easily administered, for example by simple addition to feed of an animal and is and non-toxic to the animals, providing a safe and efficient means for controlling populations of mammals and avian species.
Claims
exact text as granted — not AI-modified1 . A method of reversibly inhibiting sperm receptor synthesis and assembly in animals comprising:
administering to said animals an effective amount of nicarbazin and a carrier, verifying inhibition of zona pellucida protein C (ZPC) in said animals, and stopping administration to said animals to reversibly restore ZPC in said animals.
2 . The method of claim 1 wherein said administration is selected from the group consisting of: intravenously, intradermally, intraarterially, intraperitoneally, intranasally, intravitreally, intravaginally, intrarectally, topically, intramuscularly, intraperitoneally, subcutaneously, mucosally, intrapericardially, orally, topically, locally, inhalation (e.g., aerosol inhalation), injection, infusion, and continuous infusion.
3 . The method of claim 2 wherein said administration is orally.
4 . The method of claim 1 wherein said animal is a non-human.
5 . The method of claim 1 wherein said animal is a mammal.
6 . The method of claim 1 wherein said animal is a rat.
7 . The method of claim 1 wherein said animal is a mouse.
8 . The method of claim 1 wherein said carrier is polyethylene glycol.
9 . The method of claim 1 further comprising measuring ZPC.
10 . The method of claim 1 wherein said administration is by combining said nicarbazin with food.
11 . The method of claim 10 wherein said animal is a rat.
12 . The method of claim 10 wherein said animal is a mouse.
13 . A method of reversibly inhibiting sperm receptor synthesis and assembly in mammals comprising:
administering to a mammal in need of contraception an effective amount of nicarbazin and a carrier, inhibiting zona pellucida protein C (ZPC) in said mammal, and stopping administration to said mammals to reversibly restore ZPC in said mammals to restore fertility and allow said mammals to produce offspring.
14 . The method of claim 13 wherein said administration is selected from the group consisting of: intravenously, intradermally, intraarterially, intraperitoneally, intranasally, intravitreally, intravaginally, intrarectally, topically, intramuscularly, intraperitoneally, subcutaneously, mucosally, intrapericardially, orally, topically, locally, inhalation (e.g., aerosol inhalation), injection, infusion, and continuous infusion.
15 . The method of claim 13 wherein said administration is orally.
16 . The method of claim 13 wherein said carrier is polyethylene glycol.
17 . The method of claim 13 wherein said administration is by combining said nicarbazin with food.
18 . The method of claim 13 wherein said mammal is a non-human.
19 . The method of claim 13 wherein said mammal is a rat.
20 . The method of claim 13 wherein said mammal is a mouse.
21 . The method of claim 13 further comprising measuring ZPC.Join the waitlist — get patent alerts
Track US2011034494A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.